Opinion|Videos|March 11, 2024

Step-Up Dosing of Bispecifics in the Outpatient Setting for Patients with Multiple Myeloma

Michael Singel, PharmD; and Carol Ann Huff, MD, discuss how step-up dosing for bispecific antibodies has been implemented in the outpatient setting with monitoring considerations for cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome to ensure patient safety.

Episodes in this series


Latest CME